secwatch.observer — SEC 8-K summary
======================================

Issuer:     Camp4 Therapeutics Corp (CAMP)
CIK:        0001736730
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001736730-25-000043
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CAMP4 Therapeutics annual meeting elects four Class I directors, ratifies EY as auditor
--------------------------------------------------------------------------------

- James Boylan elected with 15,802,709 votes for, 900,961 against, 6,002 abstain.
- Amir Nashat, Andrew Schwab, and Douglas Williams each elected with >16 million votes for.
- Ratification of Ernst & Young as auditor for FY2025: 17,900,199 for, 2,644 against, 6,002 abstain.
- All proposals passed; meeting held June 11, 2025 as scheduled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/0001736730-25-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/camp-20250611.htm
  HTML page:      https://secwatch.observer/filing/0001736730-25-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer